BUPLANT Trademark

Trademark Overview

On Thursday, April 21, 2016, a trademark application was filed for BUPLANT with the United States Patent and Trademark Office. The USPTO has given the BUPLANT trademark a serial number of 87009766. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 9, 2019. This trademark is owned by Titan Pharmaceuticals, Inc.. The BUPLANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases
buplant

General Information

Serial Number87009766
Word MarkBUPLANT
Filing DateThursday, April 21, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 9, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2016

Trademark Statements

Goods and ServicesPharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 26, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTitan Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameTitan Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, December 9, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 9, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 3, 2019EXTENSION 5 GRANTED
Tuesday, April 30, 2019EXTENSION 5 FILED
Friday, May 3, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 30, 2019TEAS EXTENSION RECEIVED
Tuesday, October 30, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 26, 2018EXTENSION 4 GRANTED
Friday, October 26, 2018EXTENSION 4 FILED
Friday, October 26, 2018TEAS EXTENSION RECEIVED
Wednesday, May 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 30, 2018EXTENSION 3 GRANTED
Monday, April 30, 2018EXTENSION 3 FILED
Monday, April 30, 2018TEAS EXTENSION RECEIVED
Wednesday, March 28, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, September 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 25, 2017EXTENSION 2 GRANTED
Monday, September 25, 2017EXTENSION 2 FILED
Monday, September 25, 2017TEAS EXTENSION RECEIVED
Wednesday, April 26, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 24, 2017EXTENSION 1 GRANTED
Monday, April 24, 2017EXTENSION 1 FILED
Monday, April 24, 2017TEAS EXTENSION RECEIVED
Tuesday, November 8, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 24, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 5, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 5, 2016ASSIGNED TO EXAMINER
Tuesday, April 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 25, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

buplant system formulation matrix sustained pharmaceuticals treatment drugs based release drug